PFIZER INC (PFE) - Price, trends, fundamentals and chart - Passport to Wall Street

PFIZER INC (NYSE: PFE)

Overview

current price

$26.36

$26.36

change

0.59 | 2.29%

0.59 | 2.29%

Yesterday's Close

25.77

open

25.70

volume

116.34 M

30d. avg volume.

47.85 M

1 day

25.70 - 26.49

52 weeks

24.48 - 31.54

p/e

35.15

beta

0.6513

market cap

149.38 B

dividend yield

6.53%

Industry

-

News and Commentary

Market Update: Dow Falls 260 Points Ahead of FOMC Decision Stocks were lower Tuesday as market participants looked for direction ahead of the Federal Reserve's final monetary policy decision of the year. The Dow Jones Industrial Average...

Pfizer Does Not Anticipate Material Changes To US Vaccine Policy From The Incoming Administration In... On Tuesday, Pfizer Inc. (PFE

Biden Proposes Medicare, Medicaid Access For Popular Weight-Loss Drugs The Biden-Harris Administration has proposed expanding Medicare and Medicaid coverage for anti-obesity medications, aiming to address the high costs that have drawn criticism. In...

Pfizer Stock Drops 10% In November On News Of Kennedy's HHS Nomination Pfizer Inc (PFE

Market Update: Stocks Slip Lower as Postelection Rally Falters Stocks declined on Friday as the postelection rally waned, leading all three major averages to post weekly losses. The Dow Jones Industrial Average sunk over 300 points, while th...

Moderna's Q3 Earnings Beat Overshadowed By Vaccine Demand Slowdown And Market Share Concerns, Analys... On Thursday, Moderna Inc. (MR...

Market Update: Nasdaq Rises to Record Ahead of Big Tech Results The Nasdaq Composite climbed to a new record close on Tuesday ahead of big tech earnings later this week. The tech-heavy index rose nearly 0.8% to settle at 18,712.75 for the fir...

Pfizer Q3 Earnings: Revenue And Profit Beat On Heightened Demand For Paxlovid, Expects $10 Billion I... On Tuesday, Pfizer Inc. (PFE

Market Update: Dow Jumps 270 Points Ahead of Busy Earnings Week Stocks rose higher Monday as investors looked ahead towards a busy week of mega-cap tech earnings and the final days before the U.S. presidential election. The Dow Jones Industri...

FDA Approves Pfizer's Respiratory Syncytial Virus Vaccine Abrysvo For Adults Below 60 Years On Tuesday, the FDA approved Pfizer Inc's (

StockTwits

StockTwits

Join now and unlock premium features

Access to premium stock and ETF data including financials, holdings and more
Participate in trading contests and earn real prizes
Sync you favorite articles and symbols between all of your device
And much more